Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

40.91%

31.34%

64.90%

Annual Dental Visits (ADV) Total

45.47%

45.66%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

43.94%

48.06%

46.74%

Appropriate Testing for Pharyngitis (CWP)

64.36%

62.64%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

90.70%

90.36%

93.08%

Asthma Medication Ratio (AMR) Total

53.90%

57.69%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

67.36%

62.96%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

NQ

52.80%

68.61%

Breast Cancer Screening (BCS)

39.60%

47.30%

55.25%

Cervical Cancer Screening (CCS)

37.96%

37.71%

59.85%

Childhood Immunization Status (CIS) Combination #10

25.06%

25.33%

35.04%

Chlamydia Screening in Women (CHL) Total

54.88%

58.06%

61.07%

Controlling High Blood Pressure (CBP)

54.74%

39.66%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

73.26%

75.30%

80.86%

Eye Exam for Patients With Diabetes (EED)

NQ

36.74%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

11.91%

30.77%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

52.25%

46.25%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

33.17%

34.32%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

36.71%

42.14%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

NA

NA

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

NQ

44.28%

55.72%

Immunizations for Adolescents (IMA) Combination #2

30.66%

31.39%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

19.98%

21.79%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

39.08%

38.74%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

37.80%

40.91%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

12.53%

16.40%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

54.39%

60.98%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

70.18%

73.17%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

85.68%

125.28%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

75.43%

83.70%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

66.18%

64.23%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

16.26%

12.22%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

2.24%

3.62%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

77.57%

76.42%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

67.47%

64.81%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

58.29%

60.85%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

64.03%

55.03%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

68.85%

66.67%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

78.26%

76.00%

75.44%

Use of Opioids at High Dosage (HDO)

5.47%

1.55%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

6.90%

1.60%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

71.05%

59.37%

83.21%